Smith Group Asset Management’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
Smith Group Asset Management's PAHC Position: Q2 2026 in Review
Smith Group Asset Management increased its Phibro Animal Health (PAHC) stake by 1.5% in Q2 2026, buying an estimated $16.3K and bringing the position to 25,407 shares worth $798K. The position accounts for 0.03% of the portfolio, ranked #118.
Smith Group Asset Management first reported a position in PAHC in Q3 2018 and has held it in 10 quarters since. The position peaked at $1.38M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.
- Smith Group Asset Management held 25,407 shares of Phibro Animal Health worth $798K as of Q2 2026.
- Smith Group Asset Management bought 386 Phibro Animal Health shares in Q2 2026, an estimated $16.3K.
- Phibro Animal Health made up 0.03% of Smith Group Asset Management's portfolio in Q2 2026, its #118 holding.
- Smith Group Asset Management first reported a position in Phibro Animal Health in Q3 2018 and has held it in 10 quarters since.
- Smith Group Asset Management's Phibro Animal Health position peaked at $1.38M in Q1 2026.
- 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.
Based on Smith Group Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.